ATYPICAL HEMOLYTIC SYNDROME INDUCED BY PEMBROLIZUMAB. MANAGEMENT AND OUTCOMES.

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/14d9782163f13f9204638185846aea72.pdf

Abstract Title

First Name *

Natallia

Last Name *

Maroz

Co-author 1

Ashantice Higgins ashantice.higgins@wright.edu Wright State University/Kettering Health Internal Medicine/Hematology and Oncology Dayton

Co-author 2

John Harcha john.harcha@ketteringhealth.org Kettering Health Internal Medicine/Hematology and Oncology Dayton

Co-author 3

Kelsey Marshall kelsey.marshall@ketteringhealth.org Kettering Health Internal Medicine/Hematology and Oncology Dayton

Co-author 4

Derek Jernigan derek.jernigan@ketteringhealth.org Kettering Health Internal Medicine Dayton

Co-author 5

Co-author 6

Co-author 7

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15